S2 Table - by Yong-Rae Kim (19797278)

Subjects:

Participant characteristics (<i>n</i> = 34). by Yong-Rae Kim (19797278)

Subjects:

S4 Table - by Yong-Rae Kim (19797278)

Subjects:

S6 Table - by Yong-Rae Kim (19797278)

Subjects:

The images of erosion control dams (ECDs) with three different exteriors. by Yong-Rae Kim (19797278)

Subjects:

DALYs rate and SDI across all regions between1990 and 2021 (a). DALYs rate across all countries in 2021 by SDI (b). DALYs disability-adjusted life years, SDI socio-demographic inde... by Juanjuan Li (399633)

Subjects:

Comparison of SD method scores between three ECDs (<i>n</i> = 34; *<i>p</i> < 0.05 using Friedman test with Bonferroni’s correction). by Yong-Rae Kim (19797278)

Subjects:

Effects of busulfan treatment (6 mg/kg) on the epididymis and sperm of mice over a three-week period. by Lingjun Zhao (21763122)

“…<p>(A) The epididymal sperm concentrations decrease over time and significantly differ between hour 0 (control) and day 21 (<i>n </i>= 3 per group). …”

CCND1 is a target gene of miR-1247-3p. by Dequan Wang (6007007)

Subjects:

Genes show significant expression change in meta-analysis and their connection with Sjogren’s syndrome and thyroid cancer. by Fanyong Kong (20700261)

“…A gene in red indicates significantly increased expression in the meta-analysis, whereas a gene in blue indicates significantly decreased expression in the meta-analysis.…”

<i>Gpdh1; Ldh</i> double mutants display increased <i>upd3</i> expression. by Madhulika Rai (4352803)

Estimated marginal means (± SE) of durations of momentary frequency of highest amplitude (MFHA). by Micha Keller (11312748)

“…The most marked change can be seen during CVH intervention, with a significant increase in LF and a significant decrease in IM duration.…”

Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx by Juan Chen (61123)

“…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatotic liver disease (MASLD) groups,... by Laia Bertran (3685147)

The strength of the commute time-functional connectivity relationship demonstrates weak pathological significance and weak dependency on age. by Rostam M. Razban (22232522)

“…The corresponding Kolmogorov-Smirnov pairwise tests are not significant (S5 Table in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0331085#pone.0331085.s001" target="_blank">SI</a>). …”

Spearman correlation matrix analysis of the RAAS system and glucose metabolism indexes in hypertensive (A) and normotensive (B) patients. by Ningning Wang (560944)

Subjects:

Table 1_Fertilization decreases the effect of ammonium nitrogen on microorganisms in Chinese Carex tibetikobresia meadows during rest-grazing.docx by Xuanbo Zhou (19374205)

Illustrative images of the processing of a myocardial perfusion study in a patient with Chagas disease. by Káryta Suely Macêdo Martins (22404155)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…UCB-Treg and ruxolitinib combination also downregulates the soluble form of inflammatory cytokines including IFN-γ, IP-10, TNF-α, IL-6, sCD40L, IL-17A, IL-17F, IL-1α, and LIF in cocultures. The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”